atosiban 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
oxytocin antagonists 3008 90779-69-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • atosiban acetate
  • atosiban
  • Antocin II
  • antocin
  • tractocil
  • tractocile
Atosiban is a synthetic peptide which is a competitive antagonist of human oxytocin at receptor level. In human pre-term labour, atosiban at the recommended dosage antagonises uterine contractions and induces uterine quiescence.
  • Molecular weight: 994.19
  • Formula: C43H67N11O12S2
  • CLOGP: -0.02
  • LIPINSKI: 3
  • HAC: 23
  • HDO: 11
  • TPSA: 365.67
  • ALOGS: -4.28
  • ROTB: 18

Drug dosage:

DoseUnitRoute
165 mg P

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Jan. 20, 2000 EMA Ferring Pharmaceuticals A/S

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Premature delivery 757.29 252.17 155 829 30126 63457912
Normal labour 632.23 252.17 77 907 440 63487598
Delivery 547.13 252.17 76 908 1327 63486711
Maternal exposure during pregnancy 525.27 252.17 173 811 219889 63268149
Product use in unapproved indication 318.88 252.17 114 870 178966 63309072

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Premature delivery 159.77 127.24 31 209 23436 79720712
Maternal exposure during pregnancy 137.55 127.24 38 202 136500 79607648

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC G02CX01 GENITO URINARY SYSTEM AND SEX HORMONES
OTHER GYNECOLOGICALS
OTHER GYNECOLOGICALS
Other gynecologicals
MeSH PA D006727 Hormone Antagonists
MeSH PA D012102 Reproductive Control Agents
MeSH PA D015149 Tocolytic Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Prevention of Premature Labor indication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 12.81 acidic
pKa2 12.85 acidic
pKa3 13.13 acidic
pKa4 13.53 acidic
pKa5 13.54 acidic
pKa6 13.87 acidic
pKa7 9.93 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Oxytocin receptor GPCR ANTAGONIST Ki 7.96 CHEMBL DRUG LABEL
Vasopressin V1a receptor GPCR Ki 9.82 CHEMBL
Vasopressin V1b receptor GPCR Ki 7.36 CHEMBL
Vasopressin V2 receptor GPCR Ki 6.48 CHEMBL
Oxytocin receptor GPCR Ki 7.40 CHEMBL

External reference:

IDSource
D03008 KEGG_DRUG
914453-95-5 SECONDARY_CAS_RN
C0164398 UMLSCUI
CHEBI:135899 CHEBI
CHEMBL382301 ChEMBL_ID
DB09059 DRUGBANK_ID
C047046 MESH_SUPPLEMENTAL_RECORD_UI
2213 IUPHAR_LIGAND_ID
6392 INN_ID
081D12SI0Z UNII
5311010 PUBCHEM_CID
59639 RXNORM
008327 NDDF
008328 NDDF
326166008 SNOMEDCT_US
391792002 SNOMEDCT_US
427147004 SNOMEDCT_US

Pharmaceutical products:

None